Dr. Narkewicz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13123 E 16th Ave
B290
Aurora, CO 80045Phone+1 720-777-6669Fax+1 720-777-7267- Is this information wrong?
Summary
- Dr. Michael Narkewicz is a pediatric gastroenterologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital, Children's Hospital Colorado, Billings Clinic, and Saint Joseph Hospital. He received his medical degree from The Robert Larner, M.D. College of Medicine at The University of Vermont and has been in practice 34 years. He specializes in pediatric hepatology and liver transplantation.
Education & Training
- University of ColoradoFellowship, Pediatric Gastroenterology, 1986 - 1989
- University of ColoradoResidency, Pediatrics, 1983 - 1986
- University of Vermont College of MedicineClass of 1983
Certifications & Licensure
- CO State Medical License 1986 - 2025
- MT State Medical License 1999 - 2025
- WY State Medical License 2021 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Awards, Honors, & Recognition
- Treasurer North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
- Fellow American Association for the Study of Liver Disease
- Member APS
- Join now to see all
Clinical Trials
- A Prospective Database of Infants With Cholestasis Start of enrollment: 2004 Apr 21
- Biliary Atresia Study in Infants and Children Start of enrollment: 2006 May 16
- Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) Start of enrollment: 2007 Nov 30
- Join now to see all
Publications & Presentations
PubMed
- Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.Jennifer T Duong, Christopher E Pope, Hillary S Hayden, Carson Miller, Stephen J Salipante, Steven M Rowe, George M Solomon, David Nichols, Lucas R Hoffman, Michael R ...> ;Journal of Cystic Fibrosis. 2024 Mar 6
- Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper.Bodewes, F., Debray, D., Scheers, I., Verkade, H., Freeman, A., Weymann, A., Narkewicz, M.> ;Journal of Pediatric Gastroenterology and Nutrition. 2024 Jan 1
- Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence.Brigham, D., Narkewicz, M.> ;Therapeutics and Clinical Risk Management. 2024 Jan 1
- Join now to see all
Press Mentions
- Ultrasound Patterns May Predict CF Liver Disease, Study SuggestsMarch 4th, 2020
- Researchers Find Test to ID Children at Higher Risk for Cystic Fibrosis Liver DiseaseFebruary 12th, 2020
- Studying Trikafta for Better Cystic Fibrosis CareJanuary 31st, 2020
- Join now to see all
Professional Memberships
- Fellow
- North American Society for Pediatric Gastroenterology, Hepatology and NutritionMember
Hospital Affiliations
- Children's Hospital ColoradoAurora, Colorado
- Billings ClinicBillings, Montana
- SCL Health - Saint Joseph HospitalDenver, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: